Protocols
1 protocol(s) meet the specified criteria
Drug: OFATUMUMAB
Protocol No.TitleStatus
CALGB50904A Randomized Phase II Trial of Ofatumumab and Bendamustine Vs. Ofatumumab, Bortezomib (NSC #681239, IND #58443) and Bendamustine in Patients with Untreated Follicular Lymphoma Open (affiliates only)